Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
46 | 3 | VIROLOGY//HIV 1//AIDS RESEARCH AND HUMAN RETROVIRUSES | 102919 |
96 | 2 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//INFECTIOUS DISEASES | 26037 |
2829 | 1 | ROYAL FREE HIV MED//ANTIRETROVIRAL THERAPY//AIDS | 2167 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ROYAL FREE HIV MED | address | 351838 | 3% | 37% | 66 |
2 | ANTIRETROVIRAL THERAPY | authKW | 225654 | 13% | 6% | 278 |
3 | AIDS | journal | 158327 | 14% | 4% | 309 |
4 | HAART | authKW | 140156 | 6% | 7% | 139 |
5 | CD4 CELL COUNT | authKW | 131427 | 2% | 20% | 46 |
6 | VIRAL LOAD | authKW | 130315 | 6% | 7% | 136 |
7 | INFECTIOUS DISEASES | WoSSC | 93244 | 61% | 0% | 1327 |
8 | AIDS THER Y EVALUAT | address | 92651 | 1% | 28% | 23 |
9 | HIV 1 RNA | authKW | 84884 | 1% | 20% | 29 |
10 | PRIMARY CARE POPULAT SCI | address | 81467 | 4% | 7% | 81 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Infectious Diseases | 93244 | 61% | 0% | 1327 |
2 | Virology | 28593 | 28% | 0% | 599 |
3 | Immunology | 21085 | 47% | 0% | 1017 |
4 | Microbiology | 3171 | 17% | 0% | 368 |
5 | Medicine, General & Internal | 2279 | 16% | 0% | 350 |
6 | Pharmacology & Pharmacy | 614 | 12% | 0% | 264 |
7 | Public, Environmental & Occupational Health | 121 | 5% | 0% | 98 |
8 | Medicine, Research & Experimental | 66 | 3% | 0% | 72 |
9 | Social Sciences, Biomedical | 22 | 1% | 0% | 13 |
10 | Health Policy & Services | 17 | 1% | 0% | 16 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ROYAL FREE HIV MED | 351838 | 3% | 37% | 66 |
2 | AIDS THER Y EVALUAT | 92651 | 1% | 28% | 23 |
3 | PRIMARY CARE POPULAT SCI | 81467 | 4% | 7% | 81 |
4 | COPENHAGEN HIV PROGRAM | 69788 | 1% | 40% | 12 |
5 | INFECT DIS | 37402 | 21% | 1% | 458 |
6 | BASEL HIV | 37387 | 0% | 43% | 6 |
7 | AIDS | 36340 | 5% | 2% | 113 |
8 | COORDINATING EUROSIDA | 32718 | 0% | 75% | 3 |
9 | INFECT DIS AIDS IMMUNOPATHOGENESIS | 32718 | 0% | 75% | 3 |
10 | EUROSIDA COORDINATING | 32712 | 0% | 38% | 6 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | AIDS | 158327 | 14% | 4% | 309 |
2 | ANTIVIRAL THERAPY | 62287 | 4% | 5% | 91 |
3 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 59160 | 4% | 5% | 86 |
4 | HIV MEDICINE | 34243 | 2% | 5% | 52 |
5 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 32396 | 5% | 2% | 100 |
6 | HIV CLINICAL TRIALS | 28304 | 1% | 6% | 32 |
7 | JOURNAL OF INFECTIOUS DISEASES | 19060 | 7% | 1% | 154 |
8 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 16101 | 4% | 1% | 78 |
9 | INTERNATIONAL JOURNAL OF STD & AIDS | 6709 | 2% | 1% | 44 |
10 | CLINICAL INFECTIOUS DISEASES | 5754 | 3% | 1% | 73 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTIRETROVIRAL THERAPY | 225654 | 13% | 6% | 278 | Search ANTIRETROVIRAL+THERAPY | Search ANTIRETROVIRAL+THERAPY |
2 | HAART | 140156 | 6% | 7% | 139 | Search HAART | Search HAART |
3 | CD4 CELL COUNT | 131427 | 2% | 20% | 46 | Search CD4+CELL+COUNT | Search CD4+CELL+COUNT |
4 | VIRAL LOAD | 130315 | 6% | 7% | 136 | Search VIRAL+LOAD | Search VIRAL+LOAD |
5 | HIV 1 RNA | 84884 | 1% | 20% | 29 | Search HIV+1+RNA | Search HIV+1+RNA |
6 | DISCORDANT RESPONSE | 79171 | 0% | 78% | 7 | Search DISCORDANT+RESPONSE | Search DISCORDANT+RESPONSE |
7 | HIV RNA | 74983 | 1% | 18% | 29 | Search HIV+RNA | Search HIV+RNA |
8 | CD4 LYMPHOCYTE COUNT | 65801 | 1% | 17% | 27 | Search CD4+LYMPHOCYTE+COUNT | Search CD4+LYMPHOCYTE+COUNT |
9 | HIGHLY ACTIVE ANTIRETROVIRAL THERAPY | 60174 | 3% | 6% | 65 | Search HIGHLY+ACTIVE+ANTIRETROVIRAL+THERAPY | Search HIGHLY+ACTIVE+ANTIRETROVIRAL+THERAPY |
10 | VIREMIA COPY YEARS | 58169 | 0% | 100% | 4 | Search VIREMIA+COPY+YEARS | Search VIREMIA+COPY+YEARS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |